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THERE IS A LOW RATE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN 
CHEST PAIN PATIENTS WITH A MODERATE RISK HEART SCORE REFERRED 
FROM URGENT CARE FOR EXPEDITED OUTPATIENT CARDIOLOGY 
EVALUATION: A MULTI-CENTER STUDY
Highlights
This was the first experience of an expedited outpatient cardiology evaluation for stable patients who present 
to urgent care with chest pain and HEART score 4–6. This approach was proven to be safe, effective, and 
associated with low risk of myocardial infarction and no death due to delay of care during 6 weeks of follow-up.
Background
The HEART score is an effective method of risk stratifying emergency department (ED)
patients with chest pain. The rate of major adverse cardiovascular events (MACE) 
in patients with moderate HEART score referred from an urgent care (UC) for an 
expedited outpatient cardiology evaluation for 11 months was described in 133 patients 
in a previous study. This is a follow-up study with 18 months of data and 206 patients.
Aim
The primary outcome was to examine the rate of MACE when patients with 
moderate HEART score were referred for an expedited outpatient cardiology 
follow-up after evaluation in urgent care. The secondary outcome was to determine 
if there is a decrease in rate of ED transfer after this protocol was introduced.
Methods
A cross-sectional study was conducted by a multispecialty group in Las Vegas, 
Nevada, which included 206 patients with a HEART score of 4 to 6 (i.e.: moderate 
risk) who presented to one of five UC centers with chest pain or an anginal equivalent. 
A streamlined evaluation protocol to assess each HEART score component was 
adopted by all UC providers to facilitate an expedited outpatient cardiology follow-up,
as an alternative to referral to the emergency department. Data was collected from 
February 14, 2019 through August 13, 2020. The population was followed for 6 weeks 
with a primary endpoint of MACE determined by electronic medical record review 
and direct phone contact with patients. Outcomes were confirmed in 98% of patients. 
Chest pain transfer data was compared between 12 months prior to implementing 
HEART protocol and 18 months of data analysis while using the new protocol.
Results
Over the course of 18 months, 206 patients with a moderate risk HEART score were 
referred to outpatient cardiology in an expedited manner. The average age was 65 with 
53% female and 47% male patients. 150 patients (73% of the 206) were seen within 3 
days, 114 (55%) underwent stress testing, 6 (3%) had coronary computed tomography 
angiogram, and 6 (3%) received an invasive coronary angiogram. Five patients were 
found to have MACE: one patient who had a non-ST-elevation myocardial infarction 
and subsequent coronary stent, two patients were found to have obstructive disease 
after coronary angiography with subsequent coronary artery bypass graft, one patient 
had an abnormal stress test and subsequent coronary stent, and one patient had critical 
mitral stenosis, multi-vessel coronary artery disease and underwent coronary artery 
bypass graft with mitral valve replacement with complications of renal failure and 
COVID-19 and expired. The emergency department referral rate declined by 21%.
Conclusion
Patients with a moderate risk HEART score referred from UC for an expedited 
outpatient cardiology evaluation had a low rate of MACE and no deaths due to 
delay of care. There was also a significant decrease in the rate of ED referrals.
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Introduction
The HEART score is a risk-stratification tool for 
assessing the likelihood that a patient with chest pain will 
experience a clinically important, irreversible cardiac 
event (i.e., myocardial infarction, revascularization, or 
cardiac death). Each component of the HEART score 
is assigned a point value between 0 and 2, depending 
on the extent of the abnormality. A total HEART score 
between 0 and 3 represents a 2.5% risk for an event, 
while a score >7 carries a 72.7% risk [1]. 
The advent of the HEART score [1] and it’s 
validation [2, 3], has resulted in a more appropriate 
disposition of low risk patients (HEART score 0–3) due 
to a low risk of a major adverse cardiovascular event 
(MACE), as defined by revascularization, myocardial 
infarction, or death within 4–6 weeks. In over 2,440 patients 
Backus et al showed a 1.7% risk of MACE in low-risk 
patients in the Netherlands [3] though a recent analysis of 
North American patients has shown a lower rate of 0.8% [4].
MACE outcomes for patients in the moderate-risk 
HEART category (score of 4–6), in the Netherlands 
were shown to be 17% [3], with a recommendation 
of admission for further evaluation, but less is known 
about the safety of an expedited outpatient evaluation. In 
2018, the American College of Emergency Physicians 
(ACEP) published a practice guideline for patients seen 
in the emergency department with a negative evaluation 
for chest pain, recommending follow-up within 1–2 
weeks, and an acceptable miss rate of MACE of 1–2% 
(ACEP 2018 policy statement) [5].
The rate of MACE in patients with chest pain and 
a moderate risk HEART score presenting to an Urgent 
Care center is unknown. The primary outcome of this 
study is to examine the rate of MACE after a negative 
urgent care (UC) evaluation, when this group is referred 
for an expedited outpatient cardiology follow-up within 3 
days. The secondary outcome is to determine the change in 
emergency department (ED) referral rate after the protocol 
for expedited outpatient follow-up was introduced.
Methods
A cross-sectional retrospective study was conducted 
at five UC locations. Two hundred six consecutive 
patients who presented to UC with chest pain or anginal-
equivalent (such as jaw or throat pain with exertion) 
from February 14, 2019 to August 13, 2020 and were 
assigned a HEART score 4–6 were included. Patients 
under the age of 18 or those with positive troponin, 
paced rhythm, left bundle branch block, significant 
ST-segment deviation on electrocardiogram, escalating 
angina or unstable vital signs were excluded.
Conventional troponin I was used. Only one troponin 
was done if the initial value was <0.03 ng/dl. The troponin 
(trop) was repeated for values 0.03–0.06 ng/dl (Fig. 1).
Patients were seen by UC providers including 
physicians, mostly board certified in Family Medicine, 
and advanced practice clinicians, both physician assistants 
and nurse practitioners. In cardiology follow-up, patients 
were seen by cardiologists (if new patients to the practice) 
or advanced practice clinicians (if established patients).
UC clinicians followed a predefined protocol with 
disposition recommendations for patients with an 
intermediate HEART risk score (4–6) to be scheduled 
for an expedited cardiology consultation within 3 days 
of discharge. 
Figure 1. Protocol for disposition of urgent care patients with 
chest pain
Note: CBC – complete blood count; CC – chief complaint; CP – chest 
pain; ED – emergency department; ECG – electrocardiography; 
PCP – primary care physician; UC – urgent care.
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The cardiology department created appointments 
for these patients to be scheduled directly by the UC 
staff. During the cardiology consultation, additional 
disposition decisions were made including medical 
treatment, outpatient stress testing, echocardiography, 
coronary computed tomography angiography or
a conventional coronary angiography. 
The TIMI [6] protocol was used for risk 
stratifications of patients presenting to UC with chest 
pain or angina equivalent, prior to institution of new 
HEART model in February 2019. Thus, the percentage 
of ED referral was compared between the times when 
each protocol was used.
The study was approved by UnitedHealth Group 
Office of Human Research Affairs on June 18, 2020. 
Results
Data was collected from February 14, 2019 through 
August 13, 2020. The average age was 65 with 109 female 
(53%) and 97 male (47%) patients. The population was 
followed with primary endpoint of MACE at 6 weeks 
determined by electronic medical record review and 
direct phone contact with patients (Table 1).
Over the course of 18 months, 206 patients with a 
negative UC evaluation and a moderate risk HEART 
score were referred for an expedited cardiology 
follow-up. Of the 206 patients referred for outpatient 
evaluation, 171 presented for the appointment; of these 
150 (73% of the 206) were seen within 3 days. Of 206 
patients, 114 (55%) underwent stress testing, 6 (3%) 
had coronary computed tomography angiogram, 6 (3%) 
received an invasive coronary angiogram.
Five patients were found to have MACE: one patient
who had a non-ST-elevation myocardial infarction 
(nSTEMI) and subsequent coronary stent in right 
coronary artery, two patients were found to have 
obstructive disease after coronary angiography with 
subsequent coronary artery bypass graft (CABG), one 
patient had an abnormal stress test and subsequent 
stent in left anterior descending artery and one patient 
had critical mitral valve stenosis, multivessel coronary 
artery disease and underwent CABG with mitral valve 
replacement (MVR). That patient was the only death 
identified one week following CABG/MVR complicated 
by renal and respiratory failure and COVID-19 (Table 2).
The secondary outcome was to determine if this 
protocol decreased referrals to the ED. Institution of 
the outpatient HEART protocol from February 14, 
2019 through August 13, 2020, decreased the rate of 
ED referral rate by 21%, compared to February 14, 
2018 and February 13, 2019 (Fig. 2).
The number of UC presentations for chest pain from 
February 14, 2018 to February 13, 2019 was 3,330 with 
466 transfers to the ED (14%). After introduction of the 
protocol (on February 14, 2019), UC visits for chest 
pain and referrals were reassessed: from February 14, 
2019 to August 13, 2020 there were 4,721 presentations 
for chest pain with 519 transfers (11%) representing a 
21% reduction in referrals to the ED (Z statistic -4.6992,
p<0.00001, 95% confidence interval).
Discussion
Though clinicians still have considerable concern 
for MACE when discharging patients from ED with 
chest pain [7], the practice of referring patients with 
a low risk HEART score for outpatient evaluation
Table 2. Patients referred for expedited outpatient cardiology follow-up with MACE within 6 weeks
Note: CABG – coronary artery bypass graft; CAD – coronary artery disease; CHF – congestive 
heart failure; CP – chest pain; DES – drug eluting stent; DOE – dyspnea on exertion; 
ECG – electrocardiography; LAD – left anterior descending; LHC – left heart catheterization; 
MACE – major adverse cardiovascular event; MVR – mitral valve replacement; nSTEMI – non-
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Table 1. Patient demographics 
Note: CVA – cerebrovascular 
















Tobacco abuse 33 (16%)
CVA/TIA 18 (9%)












has become more widely accepted. Less 
is known about the risk of patients with a 
moderate risk HEART score and safety of 
referring them from UC for an expedited 
outpatient cardiology evaluation.
After introduction of a protocol to 
evaluate UC patients with chest pain as 
outpatients, over a span of 18 months, 
only 5 of 206 patients had a MACE; one 
with a positive stress test and subsequent 
stent to the left anterior descending, 
two with subsequent CABGs,  one 
who returned and was found to have an 
nSTEMI (note that the outpatient referral 
deviated from the instituted protocol 
with a delay in scheduling of the stress 
test), and one patient with critical mitral 
stenosis and congestive heart failure 
who was found to have severe coronary artery disease, 
underwent CABG with MVR and ultimately expired 
from his medical condition and COVID-19. 
It is the consensus of these authors that the patient 
did not expire due to a delay in care as he was seen by 
a cardiologist 2 days after presenting to urgent care, 
an echocardiogram done 2 days later showed severe 
stenosis of a bioprosthetic mitral valve implanted 11 
years earlier, and he was then admitted to the hospital 
in stable condition. His surgery was postponed by 
10 days due to worsening of baseline abnormal renal 
function and unfortunately expired due to postoperative 
complications of renal failure and COVID-19 with a 
cardiac arrest about 10 days after the surgery.
The risk of MACE in patients after a negative 
evaluation is low, with one of the primary considerations 
being missed myocardial infarction. Hess et al 
demonstrated a low rate of adverse outcomes in patients 
with nSTEMI with a rate of sudden cardiac death of 
0.79% in the six months following diagnosis. Even 
in the ED setting, there is an exceedingly low risk of 
clinically relevant cardiac events including ST-elevation 
myocardial infarction, life-threatening arrhythmia, 
cardiac arrest and death [8]. After a negative evaluation 
for chest pain, patients are able better understand their 
individual risk and to make decisions using a shared 
decision-making model [9, 10]. 
To our knowledge, this is the first study to evaluate 
MACE outcomes and decreased ED referrals in UC 
patients after the institution of a protocol for expedited 
outpatient referral to cardiology over 18 months of time. 
Institution of the protocol resulted in a 21% 
decrease in patients referred from the UC to the ED, 
with subsequent potential implications including 
reduced cost, decreased resource utilization, less 
patient inconvenience and potential for over-testing 
and false positive results. 
Limitations include missed MACE outcomes with 
the 2% of patients who were not able to be contacted. 
Figure 2. Emergency department referral percentages comparing the last 12 months 
of TIMI (2/14/2018 to 2/13/2019) to the time since implementation of HEART 
protocol (2/14/2019 to 8/13/2020) for chest pain risk stratification
We did not evaluate for adverse cardiac events after the 
cardiology visit such as complications from a cardiac 
catheterization or a procedure. Past studies have shown 
that there is some clinician variation in calculation of the 
HEART score [11, 12], this study did not standardize 
the calculation and we did not examine for physician 
variation. Some patients who did not follow-up may have 
had an unrecognized MACE such as a silent myocardial 
infarction. This study is a follow up 18 month data from 
a study published previously with 11 month data [13].
Conclusions 
Patients with a moderate risk HEART score referred 
from UC for an expedited outpatient cardiology 
evaluation had a very low rate of MACE outcomes and 
no deaths from delayed care. The referral rate to the ED 
decreased by 21% during the study period. Expedited 
outpatient cardiology referral for UC patients with 
chest pain and moderate risk HEART score appears to 
be a reasonable approach for this patient population. 
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